Citadel Advisors’s PepGen PEPG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$966K Sell
399,251
-259,130
-39% -$671K ﹤0.01% 8546
2026
Q2
$1.19M Buy
658,381
+450,459
+217% +$732K ﹤0.01% 7787
2026
Q1
$368K Sell
207,922
-59,867
-22% -$336K ﹤0.01% 10001
2025
Q4
$1.74M Sell
267,789
-29,469
-10% -$153K ﹤0.01% 6207
2025
Q3
$1.37M Buy
+297,258
New +$479K ﹤0.01% 6849
2025
Q2
– Sell
-91
Closed -$128 – 14434
2025
Q1
$128 Sell
91
-26
-22% -$54 ﹤0.01% 14326
2024
Q4
$443 Buy
+117
New +$729 ﹤0.01% 14324
2022
Q4
– Sell
-343,751
Closed -$3.12M – 15299
2022
Q3
$3.12M Buy
343,751
+50,210
+17% +$494K ﹤0.01% 4740
2022
Q2
$2.92M Buy
+293,541
New +$3.27M ﹤0.01% 4805

Other funds holding PEPG

Citadel Advisors's PEPG Position: Q3 2026 in Review

Citadel Advisors reduced its PepGen (PEPG) stake by 39% in Q3 2026, selling an estimated $671K and leaving 399,251 shares worth $966K. The position accounts for ﹤0.01% of the portfolio, ranked #8546.

Citadel Advisors first reported a position in PEPG in Q2 2022 and has held it in 9 quarters since. The position peaked at $3.12M in Q3 2022. 84 funds tracked by Wall St. Rank hold PEPG as of Q3 2026.

  • Citadel Advisors held 399,251 shares of PepGen worth $966K as of Q3 2026.
  • Citadel Advisors sold 259,130 PepGen shares in Q3 2026, an estimated $671K.
  • PepGen made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #8546 holding.
  • Citadel Advisors first reported a position in PepGen in Q2 2022 and has held it in 9 quarters since.
  • Citadel Advisors's PepGen position peaked at $3.12M in Q3 2022.
  • 84 funds tracked by Wall St. Rank held PepGen as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.